Initially the idea being the collaboration with Dolphin Medical is to use the device to make it easier for clinicians to find blood vessels for the placement of catheters.
The company added new investor Felicis Ventures, and returning Seed round investors Lux Capital and ARCH Venture Partners led the Series A round.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.